Cancer Research UK logo.
SearchDonate
  • Search

A trial looking at the drugs defactinib with VS-6766 for all cancers (FRAME)

Overview

Cancer types:

All cancer types, Bowel (colorectal) cancer, Lung cancer, Non small cell lung cancer (NSCLC), Ovarian cancer, Pancreatic cancer, Womb (uterine or endometrial) cancer

Status:

Closed

Phase:

Phase 1

Details

This trial is looking at defactinib with VS-6766 for solid cancers. A is any cancer apart from leukaemia, lymphoma and myeloma.

It is open to people who can’t have or don’t want to have the for their cancer.

Recruitment start: 6 December 2017

Recruitment end: 31 January 2023

How to join

Please note: In order to you will need to discuss it with your doctor, unless otherwise specified.

Chief investigators

Professor Udai Banerji

Supported by

Institute of Cancer Research (ICR)

Chugai Pharma UK Ltd

Verastem Inc

Last reviewed: 31 Jan 2023

CRUK internal database number: 17248

Help and support